As of April 9, 2026, the CDC reports 1,714 confirmed measles cases in the United States this year, with 1,609 outbreak-associated across 33 jurisdictions and 17 new outbreaks in 2026 alone—94% of total cases. This surge, fueled by measles importations from endemic regions and vaccination coverage below the 95% herd immunity threshold (92.5% among 2024–2025 kindergartners), reflects heightened transmission in under-vaccinated communities, primarily among unvaccinated individuals. Cases rose 43 from April 2, signaling ongoing epidemiological pressure despite intensified public health responses like contact tracing and MMR campaigns. Traders should watch weekly CDC surveillance updates, expected mid-week, and state-level reports through April 30 resolution, as containment success could curb further spread.
Polymarket verilerine atıfta bulunan deneysel AI tarafından oluşturulmuş özet. Bu bir işlem tavsiyesi değildir ve bu piyasanın nasıl çözümlendiğinde hiçbir rolü yoktur. · GüncellendiABD'de 30 Nisan'a kadar kızamık vakaları?
ABD'de 30 Nisan'a kadar kızamık vakaları?
$194,638 Hac.
$194,638 Hac.
30 Nis 2026
1800
63%
1850
18%
1900
7%
1950
3%
2000
3%
2100
2%
2200
2%
$194,638 Hac.
$194,638 Hac.
30 Nis 2026
1800
$52,036 Hac.
63%
1850
$5,501 Hac.
18%
1900
$50,792 Hac.
7%
1950
$20,403 Hac.
3%
2000
$42,683 Hac.
3%
2100
$7,283 Hac.
2%
2200
$15,939 Hac.
2%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 9, 2026, the CDC reports 1,714 confirmed measles cases in the United States this year, with 1,609 outbreak-associated across 33 jurisdictions and 17 new outbreaks in 2026 alone—94% of total cases. This surge, fueled by measles importations from endemic regions and vaccination coverage below the 95% herd immunity threshold (92.5% among 2024–2025 kindergartners), reflects heightened transmission in under-vaccinated communities, primarily among unvaccinated individuals. Cases rose 43 from April 2, signaling ongoing epidemiological pressure despite intensified public health responses like contact tracing and MMR campaigns. Traders should watch weekly CDC surveillance updates, expected mid-week, and state-level reports through April 30 resolution, as containment success could curb further spread.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Piyasa Açıldı: Mar 27, 2026, 1:49 PM ET
Hacim
$194,638Bitiş Tarihi
30 Nis 2026Piyasa Açıldı
Mar 27, 2026, 1:49 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 9, 2026, the CDC reports 1,714 confirmed measles cases in the United States this year, with 1,609 outbreak-associated across 33 jurisdictions and 17 new outbreaks in 2026 alone—94% of total cases. This surge, fueled by measles importations from endemic regions and vaccination coverage below the 95% herd immunity threshold (92.5% among 2024–2025 kindergartners), reflects heightened transmission in under-vaccinated communities, primarily among unvaccinated individuals. Cases rose 43 from April 2, signaling ongoing epidemiological pressure despite intensified public health responses like contact tracing and MMR campaigns. Traders should watch weekly CDC surveillance updates, expected mid-week, and state-level reports through April 30 resolution, as containment success could curb further spread.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Hacim
$194,638Bitiş Tarihi
30 Nis 2026Piyasa Açıldı
Mar 27, 2026, 1:49 PM ETResolver
0x65070BE91...As of April 9, 2026, the CDC reports 1,714 confirmed measles cases in the United States this year, with 1,609 outbreak-associated across 33 jurisdictions and 17 new outbreaks in 2026 alone—94% of total cases. This surge, fueled by measles importations from endemic regions and vaccination coverage below the 95% herd immunity threshold (92.5% among 2024–2025 kindergartners), reflects heightened transmission in under-vaccinated communities, primarily among unvaccinated individuals. Cases rose 43 from April 2, signaling ongoing epidemiological pressure despite intensified public health responses like contact tracing and MMR campaigns. Traders should watch weekly CDC surveillance updates, expected mid-week, and state-level reports through April 30 resolution, as containment success could curb further spread.
Polymarket verilerine atıfta bulunan deneysel AI tarafından oluşturulmuş özet. Bu bir işlem tavsiyesi değildir ve bu piyasanın nasıl çözümlendiğinde hiçbir rolü yoktur. · Güncellendi
Harici bağlantılara dikkat edin.
Harici bağlantılara dikkat edin.
Sıkça Sorulan Sorular